220 related articles for article (PubMed ID: 15072449)
1. Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y.
Donzelli E; Carfì M; Miloso M; Strada A; Galbiati S; Bayssas M; Griffon-Etienne G; Cavaletti G; Petruccioli MG; Tredici G
J Neurooncol; 2004; 67(1-2):65-73. PubMed ID: 15072449
[TBL] [Abstract][Full Text] [Related]
2. Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis.
Villa D; Miloso M; Nicolini G; Rigolio R; Villa A; Cavaletti G; Tredici G
Mol Cancer Ther; 2005 Sep; 4(9):1439-47. PubMed ID: 16170037
[TBL] [Abstract][Full Text] [Related]
3. Melatonin pre-treatment mitigates SHSY-5Y cells against oxaliplatin induced mitochondrial stress and apoptotic cell death.
Waseem M; Sahu U; Salman M; Choudhury A; Kar S; Tabassum H; Parvez S
PLoS One; 2017; 12(7):e0180953. PubMed ID: 28732061
[TBL] [Abstract][Full Text] [Related]
4. Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin.
Murphy RF; Komlodi-Pasztor E; Robey R; Balis FM; Farrell NP; Fojo T
Cell Cycle; 2012 Mar; 11(5):963-73. PubMed ID: 22333583
[TBL] [Abstract][Full Text] [Related]
5. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Feb; 312(2):424-31. PubMed ID: 15496615
[TBL] [Abstract][Full Text] [Related]
6. Platinum resistance needs the mythbusters.
Stordal B; Davey R
Toxicol Lett; 2008 Aug; 180(3):230. PubMed ID: 18662757
[No Abstract] [Full Text] [Related]
7. Long-term effects after treatment with platinum compounds, cisplatin and [Pt(O,O'-acac)(γ-acac)(DMS)]: Autophagy activation in rat B50 neuroblastoma cells.
Grimaldi M; Bo VD; Ferrari B; Roda E; De Luca F; Veneroni P; Barni S; Verri M; De Pascali SA; Fanizzi FP; Bernocchi G; Bottone MG
Toxicol Appl Pharmacol; 2019 Feb; 364():1-11. PubMed ID: 30529627
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy?
Di Cesare Mannelli L; Zanardelli M; Failli P; Ghelardini C
Free Radic Biol Med; 2013 Aug; 61():143-50. PubMed ID: 23548635
[TBL] [Abstract][Full Text] [Related]
9. Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells.
Nicolini G; Rigolio R; Scuteri A; Miloso M; Saccomanno D; Cavaletti G; Tredici G
Neurochem Int; 2003 Apr; 42(5):419-29. PubMed ID: 12510025
[TBL] [Abstract][Full Text] [Related]
10. The monofunctional platinum(II) compounds, phenanthriplatin and pyriplatin, modulate apoptosis signaling pathways in HEI-OC1 auditory hybridoma cells.
Monroe JD; Johnston AM; Smith ME
Neurotoxicology; 2020 Jul; 79():104-109. PubMed ID: 32413439
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activities, cellular uptake, gene regulation, and optical imaging of novel platinum(II) complexes.
Gao J; Liu YG; Zingaro RA
Chem Res Toxicol; 2009 Oct; 22(10):1705-12. PubMed ID: 19694485
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
13. The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum.
Cerri S; Piccolini VM; Santin G; Bottone MG; De Pascali SA; Migoni D; Iadarola P; Fanizzi FP; Bernocchi G
Neurotoxicol Teratol; 2011; 33(2):273-81. PubMed ID: 20883777
[TBL] [Abstract][Full Text] [Related]
14. p38 MAPK and ERK1/2 pathways are involved in the pro-apoptotic effect of notoginsenoside Ft1 on human neuroblastoma SH-SY5Y cells.
Gao B; Shi HL; Li X; Qiu SP; Wu H; Zhang BB; Wu XJ; Wang ZT
Life Sci; 2014 Jul; 108(2):63-70. PubMed ID: 24857982
[TBL] [Abstract][Full Text] [Related]
15. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney.
Sheikh-Hamad D; Cacini W; Buckley AR; Isaac J; Truong LD; Tsao CC; Kishore BK
Arch Toxicol; 2004 Mar; 78(3):147-55. PubMed ID: 14551673
[TBL] [Abstract][Full Text] [Related]
17. Antitumour activity of oxaliplatin in neuroblastoma cell lines.
Riccardi A; Ferlini C; Meco D; Mastrangelo R; Scambia G; Riccardi R
Eur J Cancer; 1999 Jan; 35(1):86-90. PubMed ID: 10211093
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding.
Ta LE; Espeset L; Podratz J; Windebank AJ
Neurotoxicology; 2006 Dec; 27(6):992-1002. PubMed ID: 16797073
[TBL] [Abstract][Full Text] [Related]
19. Tris (1,3-dichloro-2-propyl) phosphate-induced apoptotic signaling pathways in SH-SY5Y neuroblastoma cells.
Li R; Zhou P; Guo Y; Lee JS; Zhou B
Neurotoxicology; 2017 Jan; 58():1-10. PubMed ID: 27816613
[TBL] [Abstract][Full Text] [Related]
20. The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies.
Al Moundhri MS; Al-Salam S; Al Mahrouqee A; Beegam S; Ali BH
J Med Toxicol; 2013 Mar; 9(1):25-33. PubMed ID: 22648527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
